|
Model Outcome
|
|
1-year Outcomes
|
|
|
10-year Outcomes
|
|
|
|
|
Current Resistance
|
50% Reduction in Resistance
|
50% Increase in Resistance
|
Current Resistance
|
50% Reduction in Resistance
|
50% Increase in Resistance
|
|
Hospital LOS (days)
|
Absolute
|
11 324 310
|
11 103 308
|
11 545 088 |
113 243 101
|
111 033 078
|
115 450 885 |
|
Incremental
|
– |
- 221 002
|
220 778 |
– |
-2 210 023
|
2 207 784 |
|
Defined daily dose
|
Absolute
|
11 189 782
|
11 011 342
|
11 360 556 |
111 897 822
|
110 113 416
|
113 605 562 |
|
Incremental
|
– |
- 178 441
|
170 774 |
– |
-1 784 406
|
1 707 739 |
|
Hospitalization costs (¥, USD)
|
Absolute
|
¥329 406 466 854
(US $3 085 052 370)
|
¥322 979 769 416
(US $3 024 863 212)
|
¥335 826 656 376
(US $3 145 180 579)
|
¥3 012 870 018 733
(US $28 216 998 536)
|
¥2 954 089 132 565
(US $27 666 486 842)
|
¥3 071 591 381 157
(US $28 766 952 762)
|
|
Incremental
|
– |
-¥6 426 697 438
(US -$ 60 189 159)
|
¥6 420 189 522
(US $60 128 209)
|
– |
-¥58 780 886 168
(US -$550 511 694)
|
¥58 721 362 424
(US $549 954 225)
|
|
Life years lost*
|
Absolute
|
804 542
|
550 003
|
1 103 593 |
7 358 631
|
5 030 522
|
10 093 862 |
|
Incremental
|
– |
- 254 539
|
299 051 |
– |
-2 328 109
|
2 735 230 |
|
QALYs lost+
|
Absolute
|
688 566
|
472 785
|
942 058 |
6 297 873
|
4 324 262
|
8 616 397 |
|
Incremental
|
– |
- 215 781
|
253 491 |
– |
-1 973 612
|
2 318 524 |